| R&D SYSTEMS 产品目录--泽浩公司 |
| R&D SYSTEMS 产品目录列表 page 3 >> 1 2 3 4 5 6 7 8 9 10 >>..More |
| 产品编号 |
产品描述 |
规格/包装 |
品牌 |
| 203-IL-050 |
Recombinant Human IL-3 (50 UG) |
50 UG |
R&D SYSTEMS |
| 203-IL-050/CF |
Recombinant Human IL-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2044-CD-050 |
Recombinant Human CD83/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 204-IL-010 |
Recombinant Human IL-4 (10 UG) |
10 UG |
R&D SYSTEMS |
| 204-IL-010/CF |
Recombinant Human IL-4, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 204-IL-050 |
Recombinant Human IL-4 (50 UG) |
50 UG |
R&D SYSTEMS |
| 204-IL-050/CF |
Recombinant Human IL-4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2057-IL-025 |
Recombinant Mouse IL-17F (25 UG) |
25 UG |
R&D SYSTEMS |
| 2057-IL-025/CF |
Recombinant Mouse IL-17F, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2058-CY-010 |
Recombinant Mouse Legumain/Asparaginyl Endopeptidase, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2059-SE-010 |
Recombinant Mouse Tryptase epsilon/BSSP-4, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 205-IL-005 |
Recombinant Human IL-5 (5 UG) |
5 UG |
R&D SYSTEMS |
| 205-IL-005/CF |
Recombinant Human IL-5, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 205-IL-025 |
Recombinant Human IL-5 (25 UG) |
25 UG |
R&D SYSTEMS |
| 205-IL-025/CF |
Recombinant Human IL-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2060-SE-010 |
Recombinant Human Complement Component C1s, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2069-PR-050 |
Recombinant Mouse PRDC (50 UG) |
50 UG |
R&D SYSTEMS |
| 2069-PR-050/CF |
Recombinant Mouse PRDC, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 206-IL-010 |
Recombinant Human IL-6 (10 UG) |
10 UG |
R&D SYSTEMS |
| 206-IL-010/CF |
Recombinant Human IL-6, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 206-IL-050 |
Recombinant Human IL-6 (50 UG) |
50 UG |
R&D SYSTEMS |
| 206-IL-050/CF |
Recombinant Human IL-6, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2070-GS-025 |
Recombinant Human GASP-1/WFIKKNRP (25 UG) |
25 UG |
R&D SYSTEMS |
| 2070-GS-025/CF |
Recombinant Human GASP-1/WFIKKNRP, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2074-FC-050 |
Recombinant Mouse Fc gamma RI/CD64, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2077-MB-050 |
Recombinant Mouse MBL-1 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2077-MB-050/CF |
Recombinant Mouse MBL-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2078-T4-050 |
Recombinant Human ILT4/CD85d/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 207-IL-005 |
Recombinant Human IL-7 (5 UG) |
5 UG |
R&D SYSTEMS |
| 207-IL-005/CF |
Recombinant Human IL-7, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 207-IL-025 |
Recombinant Human IL-7 (25 UG) |
25 UG |
R&D SYSTEMS |
| 207-IL-025/CF |
Recombinant Human IL-7, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2088-LN-050 |
Recombinant Human Langerin/CD207, CF |
50 µg |
R&D SYSTEMS |
| 2088-LN-050 |
Recombinant Human Langerin/CD207, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2089-LY-025 |
Recombinant Human LYVE-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 208-IL-010 |
Recombinant Human CXCL8/IL-8 (10 UG) |
10 UG |
R&D SYSTEMS |
| 208-IL-010/CF |
Recombinant Human CXCL8/IL-8, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 208-IL-050 |
Recombinant Human CXCL8/IL-8 (50 UG) |
50 UG |
R&D SYSTEMS |
| 208-IL-050/CF |
Recombinant Human CXCL8/IL-8, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2094-S6-050 |
Recombinant Human Semaphorin 6B/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2099-FB-025 |
Recombinant Bovine FGF basic (25 UG) |
25 UG |
R&D SYSTEMS |
| 2099-FB-025/CF |
Recombinant Bovine FGF basic, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 209-IL-010 |
Recombinant Human IL-9 (10 UG) |
10 UG |
R&D SYSTEMS |
| 209-IL-010/CF |
Recombinant Human IL-9, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 209-IL-050 |
Recombinant Human IL-9 (50 UG) |
50 UG |
R&D SYSTEMS |
| 209-IL-050/CF |
Recombinant Human IL-9, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2104-TS-050 |
Recombinant Human TSG-6, CF |
50 µg |
R&D SYSTEMS |
| 2104-TS-050 |
Recombinant Human TSG-6, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2105-VI-100 |
Recombinant Human Vimentin, CF |
100 µg |
R&D SYSTEMS |
| 2106-BF-010 |
Recombinant Mouse BAFF/BLyS/TNFSF13B (10 UG) |
10 UG |
R&D SYSTEMS |
| 2106-BF-010/CF |
Recombinant Mouse BAFF/BLyS/TNFSF13B, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2109-TC-050 |
Recombinant Mouse TCCR/WSX-1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 210-TA-010 |
Recombinant Human TNF-alpha/TNFSF1A (10 UG) |
10 UG |
R&D SYSTEMS |
| 210-TA-050 |
Recombinant Human TNF-alpha/TNFSF1A (50 UG) |
50 UG |
R&D SYSTEMS |
| 21112-3 |
Human IFN-alpha Fluorescein MAb (Clone MMHA-11) |
50 Tests |
R&D SYSTEMS |
| 2117-FL-025 |
Recombinant Feline IL-12/IL-23 p40 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2117-FL-025/CF |
Recombinant Feline IL-12/IL-23 p40, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2118-CL-025 |
Recombinant Canine IL-12 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2118-CL-025/CF |
Recombinant Canine IL-12, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2119-GP-050 |
Recombinant Human Glypican 3 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2119-GP-050/CF |
Recombinant Human Glypican 3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 211-TB-010 |
Recombinant Human TNF-beta/TNFSF1B (10 UG) |
10 UG |
R&D SYSTEMS |
| 211-TB-010/CF |
Recombinant Human TNF-beta/TNFSF1B, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 211-TB-050 |
Recombinant Human TNF-beta/TNFSF1B (50 UG) |
50 UG |
R&D SYSTEMS |
| 211-TB-050/CF |
Recombinant Human TNF-beta/TNFSF1B, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2120-B7-025 |
Recombinant Mouse IGFBP-rp1/IGFBP-7, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2125-LY-025 |
Recombinant Mouse LYVE-1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2126-CH-025 |
Recombinant Human CHL-1/L1CAM-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 212-GD-010 |
Recombinant Human GDNF (10 UG) |
10 UG |
R&D SYSTEMS |
| 212-GD-010/CF |
Recombinant Human GDNF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 212-GD-050 |
Recombinant Human GDNF (50 UG) |
50 UG |
R&D SYSTEMS |
| 212-GD-050/CF |
Recombinant Human GDNF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2130-SL-050 |
Recombinant Human Siglec-10/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2136-GS-025 |
Recombinant Human GASP-2/WFIKKN (25 UG) |
25 UG |
R&D SYSTEMS |
| 2136-GS-025/CF |
Recombinant Human GASP-2/WFIKKN, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 21385-3 |
Human IFN-alpha/beta R2 Phycoerythrin MAb (Clone MMHAR-2) |
50 Tests |
R&D SYSTEMS |
| 21386-3 |
Human IFN-alpha/beta R2 Fluorescein MAb (Clone MMHAR-2) |
50 Tests |
R&D SYSTEMS |
| 213-IL-005 |
Recombinant Human IL-13 (5 UG) |
5 UG |
R&D SYSTEMS |
| 213-IL-005/CF |
Recombinant Human IL-13, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 213-IL-025 |
Recombinant Human IL-13 (25 UG) |
25 UG |
R&D SYSTEMS |
| 213-IL-025/CF |
Recombinant Human IL-13, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 21400-3 |
Human IFN-beta Fluorescein MAb (Clone MMHB-3) |
50 Tests |
R&D SYSTEMS |
| 2147-CH-025 |
Recombinant Mouse CHL-1/L1CAM-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2148-LD-025 |
Recombinant Human LDL R (25 UG) |
25 UG |
R&D SYSTEMS |
| 2148-LD-025/CF |
Recombinant Human LDL R, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2149-BF-010 |
Recombinant Human BAFF/BLyS/TNFSF13B (10 UG) |
10 UG |
R&D SYSTEMS |
| 2149-BF-010/CF |
Recombinant Human BAFF/BLyS/TNFSF13B, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2150-C5-025 |
Recombinant Mouse Complement Component C5a (25 UG) |
25 UG |
R&D SYSTEMS |
| 2150-C5-025/CF |
Recombinant Mouse Complement Component C5a, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2154-B7-050 |
Recombinant Mouse B7-H4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2159-FA-050 |
Recombinant Rat Fas/TNFRSF6/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 215-GM-010 |
Recombinant Human GM-CSF (10 UG) |
10 UG |
R&D SYSTEMS |
| 215-GM-010/CF |
Recombinant Human GM-CSF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 215-GM-050 |
Recombinant Human GM-CSF (50 UG) |
50 UG |
R&D SYSTEMS |
| 215-GM-050/CF |
Recombinant Human GM-CSF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2166-TS-025 |
Recombinant Mouse Pentraxin 3/TSG-14 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2166-TS-025/CF |
Recombinant Mouse Pentraxin 3/TSG-14, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 216-MC-005/CF |
Recombinant Human M-CSF, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 216-MC-025/CF |
Recombinant Human M-CSF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 216-MCC-010/CF |
Recombinant Human M-CSF (CHO-expressed), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2175-PI-010 |
Recombinant Mouse Serpin E2/PN1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2177-GL-025 |
Recombinant Mouse GITR Ligand/TNFSF18 (aa 47-173) (25 UG) |
25 UG |
R&D SYSTEMS |
| 2177-GL-025/CF |
Recombinant Mouse GITR Ligand/TNFSF18 (aa 47-173), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2179-VC-025 |
Recombinant Human VEGF-C Wild Type (25 UG) |
25 UG |
R&D SYSTEMS |
| 2179-VC-025/CF |
Recombinant Human VEGF-C Wild Type, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 217-IL-005 |
Recombinant Human IL-10 (5 UG) |
5 UG |
R&D SYSTEMS |
| 217-IL-005/CF |
Recombinant Human IL-10, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 217-IL-025 |
Recombinant Human IL-10 (25 UG) |
25 UG |
R&D SYSTEMS |
| 217-IL-025/CF |
Recombinant Human IL-10, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2180-CA-050 |
Recombinant Human Carbonic Anhydrase I, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2184-CA-050 |
Recombinant Human Carbonic Anhydrase II, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2185-CA-050 |
Recombinant Human Carbonic Anhydrase III, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2186-CA-010 |
Recombinant Human Carbonic Anhydrase IV, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2187-CA-050/CF |
Recombinant Human Carbonic Anhydrase VIII, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2188-CA-010 |
Recombinant Human Carbonic Anhydrase IX, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2189-CA-010 |
Recombinant Human Carbonic Anhydrase X, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 218-IL-005 |
Recombinant Human IL-11 (5 UG) |
5 UG |
R&D SYSTEMS |
| 218-IL-005/CF |
Recombinant Human IL-11, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 218-IL-025 |
Recombinant Human IL-11 (25 UG) |
25 UG |
R&D SYSTEMS |
| 218-IL-025/CF |
Recombinant Human IL-11, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2190-CA-010 |
Recombinant Human Carbonic Anhydrase XII, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2194-CA-050 |
Recombinant Human Carbonic Anhydrase XIII, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2195-CA-010 |
Recombinant Human Carbonic Anhydrase XIV, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2196-SE-200 |
Human Coagulation Factor II/Thrombin, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 2197-AD-020 |
Recombinant Human ADAMTS1, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2198-AD-020 |
Recombinant Human ADAMTS5, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2199-CY-010 |
Recombinant Human Legumain/Asparaginyl Endopeptidase, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 219-IL-005 |
Recombinant Human IL-12 (5 UG) |
5 UG |
R&D SYSTEMS |
| 219-IL-005/CF |
Recombinant Human IL-12, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 219-IL-025 |
Recombinant Human IL-12 (25 UG) |
25 UG |
R&D SYSTEMS |
| 219-IL-025/CF |
Recombinant Human IL-12, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2200-SE-050 |
Recombinant Human Azurocidin/CAP37/HBP (50 UG) |
50 UG |
R&D SYSTEMS |
| 2200-SE-050/CF |
Recombinant Human Azurocidin/CAP37/HBP, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2205-CN-025 |
Recombinant Human Contactin-4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2206-PI-010 |
Recombinant Mouse Kininogen HMW (HKa), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2207-HG-025/CF |
Recombinant Mouse HGF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2208-MB-050 |
Recombinant Mouse MBL-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2208-MB-050/CF |
Recombinant Mouse MBL-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 220-BB-010 |
Recombinant Human PDGF-BB, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 220-BB-050 |
Recombinant Human PDGF-BB, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 22100-3 |
Mouse IFN-alpha Fluorescein MAb (Clone RMMA-1) |
50 Tests |
R&D SYSTEMS |
| 2215-N2-025 |
Recombinant Human Neuropilin-2/Fc Chimera, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2217-CA-050 |
Recombinant Human Cadherin-4/R-Cadherin/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 221-AA-010 |
Recombinant Human PDGF-AA, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 221-AA-050 |
Recombinant Human PDGF-AA, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2225-NK-050 |
Recombinant Mouse NKp46/NCR1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2226-GA-050 |
Recombinant Human Galectin-3 BP/Mac-2 BP, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2226-GA-050 |
Recombinant Human Galectin-3BP/MAC-2BP, CF |
50 µg |
R&D SYSTEMS |
| 2229-N2-050 |
Recombinant Human Nectin-2/CD112 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2229-N2-050/CF |
Recombinant Human Nectin-2/CD112, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 222-AB-010 |
Recombinant Human PDGF-AB, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 222-AB-050 |
Recombinant Human PDGF-AB, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 223-2A-005 |
Recombinant Human IL-2 sR alpha (5 UG) |
5 UG |
R&D SYSTEMS |
| 223-2A-005/CF |
Recombinant Human IL-2 sR alpha, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 223-2A-025 |
Recombinant Human IL-2 sR alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 223-2A-025/CF |
Recombinant Human IL-2 sR alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2238-KR-050 |
Recombinant Human KIR2DL4/CD158d, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 22400-3 |
Mouse IFN-beta Fluorescein MAb (Clone RMMB-1) |
50 Tests |
R&D SYSTEMS |
| 2240-CA-050 |
Recombinant Human Pro-Cadherin-12 (CAD-12)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 224-2B-005 |
Recombinant Human IL-2 sR beta (5 UG) |
5 UG |
R&D SYSTEMS |
| 224-2B-005/CF |
Recombinant Human IL-2 sR beta, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 224-2B-025 |
Recombinant Human IL-2 sR beta (25 UG) |
25 UG |
R&D SYSTEMS |
| 224-2B-025/CF |
Recombinant Human IL-2 sR beta, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2244-CM-050 |
Recombinant Human CEACAM-1/CD66a, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2246-FG-025 |
Recombinant Human FGF-12 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2246-FG-025/CF |
Recombinant Human FGF-12, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2249-NK-050 |
Recombinant Human NKp44/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2255-LD-025 |
Recombinant Mouse LDL R |
25 µg |
R&D SYSTEMS |
| 2255-LD-025 |
Recombinant Mouse LDL R |
25 µg |
R&D SYSTEMS |
| 2255-LD-025/CF |
Recombinant Mouse LDL R, CF |
25 µg |
R&D SYSTEMS |
| 2255-LD-025/CF |
Recombinant Mouse LDL R, CF |
25 µg |
R&D SYSTEMS |
| 2258-VL-050 |
Recombinant Mouse VLDLR,CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2267-FA-050 |
Recombinant Feline Fas/TNFRSF6/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2268-SC-025 |
Recombinant Feline SCF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2268-SC-025/CF |
Recombinant Feline SCF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2269-IL-050 |
Recombinant Human IL-17 RC, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 22701-3 |
Mouse B7-1/CD80 Fluorescein MAb (Clone RMMP-1) |
100 Tests |
R&D SYSTEMS |
| 22702-3 |
Mouse B7-1/CD80 Phycoerythrin MAb (Clone RMMP-1) |
100 Tests |
R&D SYSTEMS |
| 2270-ML-050 |
Recombinant Mouse IL-17 RC, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2274-ML-025 |
Recombinant Mouse IL-17D (25 UG) |
25 UG |
R&D SYSTEMS |
| 2274-ML-025/CF |
Recombinant Mouse IL-17D, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2275-IL-050 |
Recombinant Human IL-17 RD/SEF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2275-IL-050/CF |
Recombinant Human IL-17 RD/SEF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2276-ML-050 |
Recombinant Mouse IL-17 RD/SEF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2276-ML-050/CF |
Recombinant Mouse IL-17 RD/SEF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2277-FL-025 |
Recombinant Feline CXCL8/IL-8 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2277-FL-025/CF |
Recombinant Feline CXCL8/IL-8, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2278-SC-025 |
Recombinant Canine SCF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2278-SC-025/CF |
Recombinant Canine SCF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2279-BT-025 |
Recombinant Bovine TNF-alpha/TNFSF1A (25 UG) |
25 UG |
R&D SYSTEMS |
| 2279-BT-025/CF |
Recombinant Bovine TNF-alpha/TNFSF1A, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 227-SR-025 |
Recombinant Human IL-6 sR (25 UG) |
25 UG |
R&D SYSTEMS |
| 227-SR-025/CF |
Recombinant Human IL-6 sR, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 228-GP-010 |
Recombinant Human Soluble gp130 (10 UG) |
10 UG |
R&D SYSTEMS |
| 228-GP-010/CF |
Recombinant Human Soluble gp130, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 228-GP-050 |
Recombinant Human Soluble gp130 (50 UG) |
50 UG |
R&D SYSTEMS |
| 228-GP-050/CF |
Recombinant Human Soluble gp130, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2295-4L-025 |
Recombinant Human 4-1BB Ligand/TNFSF9 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2295-4L-025/CF |
Recombinant Human 4-1BB Ligand/TNFSF9, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2296-SL-050 |
Recombinant Mouse Siglec-2/CD22/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2297-ML-025 |
Recombinant Mouse IL-1F6/FIL1 epsilon (25 UG) |
25 UG |
R&D SYSTEMS |
| 2297-ML-025/CF |
Recombinant Mouse IL-1F6/FIL1 epsilon, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2298-ML-025 |
Recombinant Mouse IL-1F8/FIL1 eta (25 UG) |
25 UG |
R&D SYSTEMS |
| 2298-ML-025/CF |
Recombinant Mouse IL-1F8/FIL1 eta, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2299-CV-050 |
Recombinant Mouse Crossveinless-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2299-CV-050/CF |
Recombinant Mouse Crossveinless-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 229-PE-010 |
Recombinant Human PD-ECGF (10 UG) |
10 UG |
R&D SYSTEMS |
| 229-PE-010/CF |
Recombinant Human PD-ECGF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 229-PE-050 |
Recombinant Human PD-ECGF (50 UG) |
50 UG |
R&D SYSTEMS |
| 229-PE-050/CF |
Recombinant Human PD-ECGF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2300-BG-025 |
Recombinant Bovine IFN-gamma (25 UG) |
25 UG |
R&D SYSTEMS |
| 2300-BG-025/CF |
Recombinant Bovine IFN-gamma, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2304-GP-050 |
Recombinant Human Glypican 2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 230-4R-025 |
Recombinant Human IL-4 sR (25 UG) |
25 UG |
R&D SYSTEMS |
| 230-4R-025/CF |
Recombinant Human IL-4 sR, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2305-FL-025 |
Recombinant Feline IL-6 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2305-FL-025/CF |
Recombinant Feline IL-6, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2306-ML-025 |
Recombinant Mouse IL-17C (25 UG) |
25 UG |
R&D SYSTEMS |
| 2306-ML-025/CF |
Recombinant Mouse IL-17C, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2307-MB-050 |
Recombinant Human MBL (50 UG) |
50 UG |
R&D SYSTEMS |
| 2307-MB-050/CF |
Recombinant Human MBL, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2308-VN-050 |
Recombinant Human Vitronectin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2318-B3-050 |
Recombinant Human B7-H3 (4lg)/B7-H3b (50 UG) |
50 UG |
R&D SYSTEMS |
| 2318-B3-050/CF |
Recombinant Human B7-H3 (4lg)/B7-H3b, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2319-L3-050 |
Recombinant Human LAG-3/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 231-BC-025 |
Recombinant Human beta-ECGF (25 UG) |
25 UG |
R&D SYSTEMS |
| 231-BC-025/CF |
Recombinant Human beta-ECGF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2320-IL-025 |
Recombinant Human IL-1F9/IL-1 H1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2320-IL-025/CF |
Recombinant Human IL-1F9/IL-1 H1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2324-CM-025 |
Recombinant Human Chemerin (25 UG) |
25 UG |
R&D SYSTEMS |
| 2324-CM-025/CF |
Recombinant Human Chemerin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2325-CM-025 |
Recombinant Mouse Chemerin (aa 17-156) (25 UG) |
25 UG |
R&D SYSTEMS |
| 2325-CM-025/CF |
Recombinant Mouse Chemerin (aa 17-156), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2326-TS-050 |
Recombinant Mouse TSG-6, CF |
50 µg |
R&D SYSTEMS |
| 2326-TS-050 |
Recombinant Mouse TSG-6, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2327-PI-050 |
Recombinant Human Testican 1/SPOCK1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2328-PI-050 |
Recombinant Human Testican 2/SPOCK2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2329-TX-100 |
Recombinant Human Thioredoxin 80, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 232-FA-025 |
Recombinant Human FGF acidic (25 UG) |
25 UG |
R&D SYSTEMS |
| 232-FA-025/CF |
Recombinant Human FGF acidic, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2330-AC-050 |
Recombinant Mouse Osteoactivin/GPNMB/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2334-ZN-010 |
Recombinant Human Aminopeptidase PILS/ARTS1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2335-ZN-010 |
Recombinant Mouse Aminopeptidase N/ANPEP, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2336-CY-010 |
Recombinant Mouse Active Cathepsin C/DPPI, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2337-SE-010 |
Recombinant Human Kallikrein 1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2338-SE-010 |
Recombinant Human Coagulation Factor VII, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2339-PA-010 |
Recombinant Human Coagulation Factor III/Tissue Factor, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 233-FB-025 |
Recombinant Human FGF basic (146 aa) (25 UG) |
25 UG |
R&D SYSTEMS |
| 233-FB-025/CF |
Recombinant Human FGF basic (146 aa), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2340-ZN-010 |
Recombinant Human Neprilysin-2/MMEL-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2344-CA-010 |
Recombinant Mouse Carbonic Anhydrase IX, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2345-CA-010 |
Recombinant Mouse Carbonic Anhydrase XII, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2346-PI-050 |
Recombinant Mouse Testican 3/SPOCK3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2347-VE-025 |
Recombinant Human VEGF 162 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2347-VE-025/CF |
Recombinant Human VEGF 162, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2348-VN-100 |
Bovine Vitronectin, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 2349-VN-100 |
Human Vitronectin, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 234-FSE-025/CF |
Recombinant Human FGF basic (157 aa), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2354-RP-100 |
Recombinant Mouse IL-1 R6/IL-1 R rp2 (100 UG) |
100 UG |
R&D SYSTEMS |
| 2354-RP-100/CF |
Recombinant Mouse IL-1 R6/IL-1 R rp2, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 2355-GP-050 |
Recombinant Mouse Glypican 2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 235-F4-025 |
Recombinant Human FGF-4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 235-F4-025/CF |
Recombinant Human FGF-4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2365-TM-050 |
Recombinant Human TIM-3/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 2365-TM-050 |
Recombinant Human TIM-3/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2367-FC-050 |
Recombinant Human Ficolin-3, CF |
50 µg |
R&D SYSTEMS |
| 2367-FC-050 |
Recombinant Human Ficolin-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 236-EG-01M |
Recombinant Human EGF, CF (1 MG) |
1 MG |
R&D SYSTEMS |
| 236-EG-200 |
Recombinant Human EGF, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 2376-BP-025 |
Recombinant Mouse IL-22BP/Fc Chimera, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 237-F5-050 |
Recombinant Human FGF-5 (50 UG) |
50 UG |
R&D SYSTEMS |
| 237-F5-050/CF |
Recombinant Human FGF-5, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2388-PS-010 |
Recombinant Human Persephin |
10 µg |
R&D SYSTEMS |
| 2388-PS-010/CF |
Recombinant Human Persephin, CF |
10 µg |
R&D SYSTEMS |
| 238-F6-025 |
Recombinant Human FGF-6 (25 UG) |
25 UG |
R&D SYSTEMS |
| 238-F6-025/CF |
Recombinant Human FGF-6, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2390-TH-050 |
Recombinant Human Thrombospondin-4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2396-DR-050 |
Recombinant Human DDR1/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 2397-CR-050 |
Recombinant Human CRISP-3, CF |
50 µg |
R&D SYSTEMS |
| 2397-CR-050 |
Recombinant Human CRISP-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 239-A-100 |
Recombinant Human TGF-alpha, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 239-A-500 |
Recombinant Human TGF-alpha, CF (500 UG) |
500 UG |
R&D SYSTEMS |
| 2404-AC-010 |
Recombinant Human CD38, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2408-NC-050 |
Recombinant Human NCAM-1/CD56, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2409-SR-050 |
Recombinant Human SREC-I/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 240-B-002 |
Recombinant Human TGF-beta 1 (2 UG) |
2 UG |
R&D SYSTEMS |
| 240-B-002/CF |
Recombinant Human TGF-beta 1, CF (2 UG) |
2 UG |
R&D SYSTEMS |
| 240-B-010 |
Recombinant Human TGF-beta 1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 240-B-010/CF |
Recombinant Human TGF-beta 1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2414-CA-010 |
Recombinant Mouse Carbonic Anhydrase IV, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2415-CR-025 |
Recombinant Human CLC/CNTF sR alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 2415-CR-025/CF |
Recombinant Human CLC/CNTF sR alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 241-R2-025 |
Recombinant Human TGF-beta sRII (25 UG) |
25 UG |
R&D SYSTEMS |
| 241-R2-025/CF |
Recombinant Human TGF-beta sRII, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2428-FC-050 |
Recombinant Human Ficolin-2,CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 242-R3-100 |
Recombinant Human TGF-beta sRIII (100 UG) |
100 UG |
R&D SYSTEMS |
| 242-R3-100/CF |
Recombinant Human TGF-beta sRIII, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 2435-DK-010 |
Recombinant Mouse Dkk-2 |
10 µg |
R&D SYSTEMS |
| 2435-DK-010/CF |
Recombinant Mouse Dkk-2, CF |
10 µg |
R&D SYSTEMS |
| 2437-D3-050 |
Recombinant Mouse DR3/TNFRSF25/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2438-RM-050 |
Recombinant Mouse IL-2 R alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 243-B3-002 |
Recombinant Human TGF-beta 3 (2 UG) |
2 UG |
R&D SYSTEMS |
| 243-B3-002/CF |
Recombinant Human TGF-beta 3, CF (2 UG) |
2 UG |
R&D SYSTEMS |
| 243-B3-010 |
Recombinant Human TGF-beta 3 (10 UG) |
10 UG |
R&D SYSTEMS |
| 243-B3-010/CF |
Recombinant Human TGF-beta 3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2445-NG-050 |
Recombinant Rat Nogo-A/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2447-GR-050 |
Recombinant Human IGF-II R, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2449-SU-020 |
Recombinant Human Iduronate 2-Sulfatase, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2459-RM-050 |
Recombinant Human RGM-A, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 245-B5-002 |
Recombinant Amphibian TGF-beta 5 (2 UG) |
2 UG |
R&D SYSTEMS |
| 245-B5-002/CF |
Recombinant Amphibian TGF-beta 5, CF (2 UG) |
2 UG |
R&D SYSTEMS |
| 245-B5-010 |
Recombinant Amphibian TGF-beta 5 (10 UG) |
10 UG |
R&D SYSTEMS |
| 245-B5-010/CF |
Recombinant Amphibian TGF-beta 5, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2460-SE-010 |
Recombinant Human Coagulation Factor XI, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2464-EV-025 |
Recombinant Mouse EG-VEGF/PK1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2464-EV-025/CF |
Recombinant Mouse EG-VEGF/PK1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2465-BL-020 |
Recombinant Bovine IL-2 (20 UG) |
20 UG |
R&D SYSTEMS |
| 2465-BL-020/CF |
Recombinant Bovine IL-2, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2466-RA-050 |
Recombinant Equine IL-1ra/IL-1F3 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2466-RA-050/CF |
Recombinant Equine IL-1ra/IL-1F3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2467-FL-025 |
Recombinant Feline Flt-3 Ligand (25 UG) |
25 UG |
R&D SYSTEMS |
| 2467-FL-025/CF |
Recombinant Feline Flt-3 Ligand, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2469-BL-025 |
Recombinant Bovine IL-4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2469-BL-025/CF |
Recombinant Bovine IL-4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 246-LP-025 |
Recombinant Human LAP (TGF-beta 1) (25 UG) |
25 UG |
R&D SYSTEMS |
| 246-LP-025/CF |
Recombinant Human LAP (TGF-beta 1), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2470-EL-025 |
Recombinant Equine IL-5 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2470-EL-025/CF |
Recombinant Equine IL-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2479-PS-010 |
Recombinant Mouse Persephin (10 UG) |
10 UG |
R&D SYSTEMS |
| 2479-PS-010/CF |
Recombinant Mouse Persephin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 247-IL-005/CF |
Recombinant Human IL-15, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 247-IL-025 |
Recombinant Human IL-15 (25 UG) |
25 UG |
R&D SYSTEMS |
| 247-IL-025/CF |
Recombinant Human IL-15, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2484-SU-020 |
Recombinant Human Glucosamine (N-acetyl)-6-Sulfatase, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2485-SU-020 |
Recombinant Human Arylsulfatase A/ARSA, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2486-SU-020 |
Recombinant Mouse Iduronate 2-sulfatase, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2487-ZN-020 |
Recombinant Human Pappalysin-1/PAPP-A, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2488-PI-200 |
Human Serpin G1/C1 Inhibitor (Plasma), CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 2489-ZN-010 |
Recombinant Human Carnosine Dipeptidase 1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 248-BD-005/CF |
Recombinant Human BDNF, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 248-BD-025 |
Recombinant Human BDNF (25 UG) |
25 UG |
R&D SYSTEMS |
| 248-BD-025/CF |
Recombinant Human BDNF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2490-ZN-010 |
Recombinant Human Aminopeptidase P2/XPNPEP2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2494-ZN-010 |
Recombinant Mouse Aminopeptidase P2/XPNPEP2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2495-SE-010 |
Recombinant Human Spinesin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2496-ZN-010 |
Recombinant Human Insulysin/IDE, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2497-SE-010 |
Recombinant Human Plasma Kallikrein/KLKB1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2498-SE-010 |
Recombinant Mouse Plasma Kallikrein/KLKB1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2499-ZN-010 |
Recombinant Human Aminopeptidase A/ENPEP, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 249-LR-050 |
Recombinant Human LIF sR alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 249-LR-050/CF |
Recombinant Human LIF sR alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2500-ZN-010 |
Recombinant Mouse Aminopeptidase PILS/ARTS1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2504-CA-010 |
Recombinant Mouse Carbonic Anhydrase XIV, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2519-CD-050 |
Recombinant Mouse CD36/SR-B3/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 251-KG-010 |
Recombinant Human KGF/FGF-7 (10 UG) |
10 UG |
R&D SYSTEMS |
| 251-KG-010/CF |
Recombinant Human KGF/FGF-7, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 251-KG-050 |
Recombinant Human KGF/FGF-7 (50 UG) |
50 UG |
R&D SYSTEMS |
| 251-KG-050/CF |
Recombinant Human KGF/FGF-7, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2520-CH-050 |
Recombinant Mouse Chordin-Like 2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2520-CH-050/CF |
Recombinant Mouse Chordin-Like 2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2524-RL-025 |
Recombinant Rat IL-3 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2524-RL-025/CF |
Recombinant Rat IL-3, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2525-BL-025 |
Recombinant Bovine IL-5 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2525-BL-025/CF |
Recombinant Bovine IL-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2526-IL-010 |
Recombinant Human IL-27 (10 UG) |
10 UG |
R&D SYSTEMS |
| 2526-IL-010/CF |
Recombinant Human IL-27, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2527-SR-050 |
Recombinant Human SREC-II/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2529-CD-050 |
Recombinant Human CD97, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 252-PL-050 |
Recombinant Human Pleiotrophin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 252-PL-250 |
Recombinant Human Pleiotrophin, CF (250 UG) |
250 UG |
R&D SYSTEMS |
| 2530-CD-050 |
Recombinant Human CD155/PVR (50 UG) |
50 UG |
R&D SYSTEMS |
| 2530-CD-050/CF |
Recombinant Human CD155/PVR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2534-MR-050 |
Recombinant Human MMR (50 UG) |
50 UG |
R&D SYSTEMS |
| 2534-MR-050/CF |
Recombinant Human MMR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2535-MM-050 |
Recombinant Mouse MMR (50 UG) |
50 UG |
R&D SYSTEMS |
| 2535-MM-050/CF |
Recombinant Mouse MMR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 253-5R-025 |
Recombinant Human IL-5 sR alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 253-5R-025/CF |
Recombinant Human IL-5 sR alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2536-LA-025 |
Recombinant Human Layilin (25 UG) |
25 UG |
R&D SYSTEMS |
| 2536-LA-025/CF |
Recombinant Human Layilin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2538-DR-050 |
Recombinant Human DDR2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2539-FG-025 |
Recombinant Human FGF-21 |
25 µg |
R&D SYSTEMS |
| 2539-FG-025 |
Recombinant Human FGF-21 |
25 µg |
R&D SYSTEMS |
| 2539-FG-025/CF |
Recombinant Human FGF-21, CF |
25 µg |
R&D SYSTEMS |
| 2539-FG-025/CF |
Recombinant Human FGF-21, CF |
25 µg |
R&D SYSTEMS |
| 2545-PI-010 |
Recombinant Human TFPI-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2547-FG-025 |
Recombinant Human FGF-20 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2547-FG-025/CF |
Recombinant Human FGF-20, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2548-RM-025 |
Recombinant Rhesus Macaque IL-18/IL-1F4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2548-RM-025/CF |
Recombinant Rhesus Macaque IL-18/IL-1F4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 254-X-010 |
Recombinant Human CXCL5/ENA-78 (10 UG) |
10 UG |
R&D SYSTEMS |
| 254-X-010/CF |
Recombinant Human CXCL5/ENA-78, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 254-X-050 |
Recombinant Human CXCL5/ENA-78 (50 UG) |
50 UG |
R&D SYSTEMS |
| 254-X-050/CF |
Recombinant Human CXCL5/ENA-78, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2554-CD-050 |
Recombinant Mouse CD200 R1/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 2558-SA-050 |
Recombinant Mouse Pentraxin 2/SAP, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2559-BG-050 |
Recombinant Mouse beta IG-H3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 255-SC-010 |
Recombinant Human SCF (10 UG) |
10 UG |
R&D SYSTEMS |
| 255-SC-010/CF |
Recombinant Human SCF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 255-SC-050 |
Recombinant Human SCF (50 UG) |
50 UG |
R&D SYSTEMS |
| 255-SC-050/CF |
Recombinant Human SCF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 256-GF-100 |
Recombinant Human beta-NGF (100 UG) |
100 UG |
R&D SYSTEMS |
| 256-GF-100/CF |
Recombinant Human beta-NGF, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 2570-ND-050 |
Recombinant Human Nidogen-1/Entactin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 257-NT-010 |
Recombinant Human CNTF (10 UG) |
10 UG |
R&D SYSTEMS |
| 257-NT-010/CF |
Recombinant Human CNTF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 257-NT-050 |
Recombinant Human CNTF (50 UG) |
50 UG |
R&D SYSTEMS |
| 257-NT-050/CF |
Recombinant Human CNTF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2586-FT-025 |
Recombinant Feline TNF-alpha/TNFSF1A (25 UG) |
25 UG |
R&D SYSTEMS |
| 2586-FT-025/CF |
Recombinant Feline TNF-alpha/TNFSF1A, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2587-SK-050 |
Recombinant Human SLITRK5, CF |
50 µg |
R&D SYSTEMS |
| 2588-MU-050 |
Recombinant Mouse MULT-1 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2588-MU-050/CF |
Recombinant Mouse MULT-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2589-AR-025 |
Recombinant Human Artemin (25 UG) |
25 UG |
R&D SYSTEMS |
| 2589-AR-025/CF |
Recombinant Human Artemin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 258-MD-010 |
Recombinant Human Midkine, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 258-MD-050 |
Recombinant Human Midkine, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2590-PG-050 |
Recombinant Human PGRP-S (50 UG) |
50 UG |
R&D SYSTEMS |
| 2590-PG-050/CF |
Recombinant Human PGRP-S, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2595-VE-025 |
Recombinant Mouse VEGF-B 167 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2595-VE-025/CF |
Recombinant Mouse VEGF-B 167, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 259-HE-050 |
Recombinant Human HB-EGF (50 UG) |
50 UG |
R&D SYSTEMS |
| 259-HE-050/CF |
Recombinant Human HB-EGF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 259-HE-250 |
Recombinant Human HB-EGF (250 UG) |
250 UG |
R&D SYSTEMS |
| 259-HE-250/CF |
Recombinant Human HB-EGF, CF (250 UG) |
250 UG |
R&D SYSTEMS |
| 2604-FG-025 |
Recombinant Human FGF-23 |
25 µg |
R&D SYSTEMS |
| 2604-FG-025/CF |
Recombinant Human FGF-23, CF |
25 µg |
R&D SYSTEMS |
| 2607-G5-050 |
Recombinant Human Glypican 5 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2607-G5-050/CF |
Recombinant Human Glypican 5, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2608-HP-025 |
Recombinant Human HAPLN1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2616-TR-050 |
Recombinant Human TLR2, CF |
50 µg |
R&D SYSTEMS |
| 2619-KB-050 |
Recombinant Mouse Klotho beta, CF |
50 µg |
R&D SYSTEMS |
| 261-CE-010 |
Recombinant Human Betacellulin (10 UG) |
10 UG |
R&D SYSTEMS |
| 261-CE-010/CF |
Recombinant Human Betacellulin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 261-CE-050 |
Recombinant Human Betacellulin (50 UG) |
50 UG |
R&D SYSTEMS |
| 261-CE-050/CF |
Recombinant Human Betacellulin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2624-SE-010 |
Recombinant Human Kallikrein 7, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2625-SE-010 |
Recombinant Human Kallikrein 13, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2626-SE-010 |
Recombinant Human Kallikrein 14, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 262-AR-100 |
Recombinant Human Amphiregulin (100 UG) |
100 UG |
R&D SYSTEMS |
| 262-AR-100/CF |
Recombinant Human Amphiregulin, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 263-2R-050 |
Recombinant Human IL-1 sRII (50 UG) |
50 UG |
R&D SYSTEMS |
| 263-2R-050/CF |
Recombinant Human IL-1 sRII, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2634-SE-010 |
Recombinant Mouse Tryptase-5/Prss32, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2636-GS-050 |
Recombinant Human Gas1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2644-GS-050 |
Recombinant Mouse Gas1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2646-LA-025 |
Recombinant Mouse Layilin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 264-PG-010 |
Recombinant Human PlGF (10 UG) |
10 UG |
R&D SYSTEMS |
| 264-PG-010/CF |
Recombinant Human PlGF, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 264-PG-050 |
Recombinant Human PlGF (50 UG) |
50 UG |
R&D SYSTEMS |
| 264-PG-050/CF |
Recombinant Human PlGF, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 265-AN-050 |
Recombinant Human Angiogenin (50 UG) |
50 UG |
R&D SYSTEMS |
| 265-AN-050/CF |
Recombinant Human Angiogenin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 265-AN-250 |
Recombinant Human Angiogenin (250 UG) |
250 UG |
R&D SYSTEMS |
| 265-AN-250/CF |
Recombinant Human Angiogenin, CF (250 UG) |
250 UG |
R&D SYSTEMS |
| 2665-LR-050 |
Recombinant Human LAIR2, CF |
50 µg |
R&D SYSTEMS |
| 2667-CM-050 |
Recombinant Human Biglycan, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 266-IP-010 |
Recombinant Human CXCL10/IP-10 (10 UG) |
10 UG |
R&D SYSTEMS |
| 266-IP-010/CF |
Recombinant Human CXCL10/IP-10, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 266-IP-050 |
Recombinant Human CXCL10/IP-10 (50 UG) |
50 UG |
R&D SYSTEMS |
| 266-IP-050/CF |
Recombinant Human CXCL10/IP-10, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2674-RM-025 |
Recombinant Rhesus Macaque IL-13 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2674-RM-025/CF |
Recombinant Rhesus Macaque IL-13, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 267-N3-005 |
Recombinant Human NT-3 (5 UG) |
5 UG |
R&D SYSTEMS |
| 267-N3-005/CF |
Recombinant Human NT-3, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 267-N3-025 |
Recombinant Human NT-3 (25 UG) |
25 UG |
R&D SYSTEMS |
| 267-N3-025/CF |
Recombinant Human NT-3, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2688-EC-050 |
Recombinant Human ESAM/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2689-G5-050 |
Recombinant Mouse Glypican 5 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2689-G5-050/CF |
Recombinant Mouse Glypican 5, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 268-N4-005 |
Recombinant Human NT-4 (5 UG) |
5 UG |
R&D SYSTEMS |
| 268-N4-005/CF |
Recombinant Human NT-4, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 268-N4-025 |
Recombinant Human NT-4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 268-N4-025/CF |
Recombinant Human NT-4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2690-CL-050 |
Recombinant Human CL-P1/COLEC12, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 269-1R-100 |
Recombinant Human IL-1 sRI (100 UG) |
100 UG |
R&D SYSTEMS |
| 269-1R-100/CF |
Recombinant Human IL-1 sRI, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 2694-CL-100/CF |
Recombinant Human FABP2, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 2695-SE-010 |
Recombinant Human Airway Trypsin-like Protease/HAT, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2696-PG-050 |
Recombinant Mouse PGRP-S (50 UG) |
50 UG |
R&D SYSTEMS |
| 2696-PG-050/CF |
Recombinant Mouse PGRP-S, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2700-ZN-020 |
Recombinant Mouse Aminoacylase/ACY1, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2706-CL-025 |
Recombinant Human CD40 Ligand/TNFSF5 (Histidine-tagged) (25 UG) |
25 UG |
R&D SYSTEMS |
| 2706-CL-025/CF |
Recombinant Human CD40 Ligand/TNFSF5 (Histidine-tagged), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2707-RM-025 |
Recombinant Rhesus Macaque IL-5 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2707-RM-025/CF |
Recombinant Rhesus Macaque IL-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2708-MS-050 |
Recombinant Human SR-AI/MSR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2709-NP-025 |
Recombinant Mouse Neuropoietin (25 UG) |
25 UG |
R&D SYSTEMS |
| 2709-NP-025/CF |
Recombinant Mouse Neuropoietin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 270-LD-010 |
Recombinant Human CCL3/MIP-1 alpha (10 UG) |
10 UG |
R&D SYSTEMS |
| 270-LD-010/CF |
Recombinant Human CCL3/MIP-1 alpha, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 270-LD-050 |
Recombinant Human CCL3/MIP-1 alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 270-LD-050/CF |
Recombinant Human CCL3/MIP-1 alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2714-ML-025 |
Recombinant Mouse IL-1F5/FIL1 delta (25 UG) |
25 UG |
R&D SYSTEMS |
| 2714-ML-025/CF |
Recombinant Mouse IL-1F5/FIL1 delta, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2715-CA-050 |
Recombinant Human Cadherin-6/KCAD/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2716-SD-025 |
Recombinant Human/Feline CXCL12/SDF-1 beta (aa 19-93) (25 UG) |
25 UG |
R&D SYSTEMS |
| 2716-SD-025/CF |
Recombinant Human/Feline CXCL12/SDF-1 beta (aa 19-93), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2717-PG-050 |
Recombinant Human pIgR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 271-BME-010 |
Recombinant Human CCL4/MIP-1 beta (10 UG) |
10 UG |
R&D SYSTEMS |
| 271-BME-010/CF |
Recombinant Human CCL4/MIP-1 beta, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 271-BME-050 |
Recombinant Human CCL4/MIP-1 beta (50 UG) |
50 UG |
R&D SYSTEMS |
| 271-BME-050/CF |
Recombinant Human CCL4/MIP-1 beta, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2724-CD-050 |
Recombinant Human CD200/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 272-I-010 |
Recombinant Human CCL1/I-309 (10 UG) |
10 UG |
R&D SYSTEMS |
| 272-I-010/CF |
Recombinant Human CCL1/I-309, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 272-I-050 |
Recombinant Human CCL1/I-309 (50 UG) |
50 UG |
R&D SYSTEMS |
| 272-I-050/CF |
Recombinant Human CCL1/I-309, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 273-F9-025 |
Recombinant Human FGF-9 (25 UG) |
25 UG |
R&D SYSTEMS |
| 273-F9-025/CF |
Recombinant Human FGF-9, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 274-R1-050 |
Recombinant Human IL-10 sR alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 274-R1-050/CF |
Recombinant Human IL-10 sR alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2755-AS-050 |
Recombinant Mouse ASGPR1 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2755-AS-050/CF |
Recombinant Mouse ASGPR1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 275-GR-010 |
Recombinant Human CXCL1/GRO alpha (10 UG) |
10 UG |
R&D SYSTEMS |
| 275-GR-010/CF |
Recombinant Human CXCL1/GRO alpha, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 275-GR-050 |
Recombinant Human CXCL1/GRO alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 275-GR-050/CF |
Recombinant Human CXCL1/GRO alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2765-ZN-010 |
Recombinant Mouse Carboxypeptidase A1/CPA1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2767-MF-050 |
Recombinant Human MFG-E8, CF |
50 µg |
R&D SYSTEMS |
| 2769-IL-050 |
Recombinant Human IL-31 RA, CF |
50 µg |
R&D SYSTEMS |
| 276-GB-010 |
Recombinant Human CXCL2/GRO beta (10 UG) |
10 UG |
R&D SYSTEMS |
| 276-GB-010/CF |
Recombinant Human CXCL2/GRO beta, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 276-GB-050 |
Recombinant Human CXCL2/GRO beta (50 UG) |
50 UG |
R&D SYSTEMS |
| 276-GB-050/CF |
Recombinant Human CXCL2/GRO beta, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2770-LR-050 |
Recombinant Human IL-22 R, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2777-CM-050 |
Recombinant Human OBCAM, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 277-GG-010 |
Recombinant Human CXCL3/GRO gamma (10 UG) |
10 UG |
R&D SYSTEMS |
| 277-GG-010/CF |
Recombinant Human CXCL3/GRO gamma, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 277-GG-050 |
Recombinant Human CXCL3/GRO gamma (50 UG) |
50 UG |
R&D SYSTEMS |
| 277-GG-050/CF |
Recombinant Human CXCL3/GRO gamma, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2784-CL-050 |
Recombinant Mouse CLEC4F/CLECSF13, CF |
50 µg |
R&D SYSTEMS |
| 278-RN-010 |
Recombinant Human CCL5/RANTES (10 UG) |
10 UG |
R&D SYSTEMS |
| 278-RN-010/CF |
Recombinant Human CCL5/RANTES, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 278-RN-050 |
Recombinant Human CCL5/RANTES (50 UG) |
50 UG |
R&D SYSTEMS |
| 278-RN-050/CF |
Recombinant Human CCL5/RANTES, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2797-CL-050 |
Recombinant Human CD5L, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2799-ML-010 |
Recombinant Mouse IL-27 (NSO-expressed) (10 UG) |
10 UG |
R&D SYSTEMS |
| 2799-ML-010/CF |
Recombinant Mouse IL-27 (NSO-expressed), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 279-MC-010 |
Recombinant Human CCL2/MCP-1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 279-MC-010/CF |
Recombinant Human CCL2/MCP-1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 279-MC-050 |
Recombinant Human CCL2/MCP-1 (50 UG) |
50 UG |
R&D SYSTEMS |
| 279-MC-050/CF |
Recombinant Human CCL2/MCP-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2800-PG-050 |
Recombinant Mouse pIgR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2805-MF-050 |
Recombinant Mouse MFG-E8 (50 UG) |
50 UG |
R&D SYSTEMS |
| 2805-MF-050/CF |
Recombinant Mouse MFG-E8/CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2809-ZN-010 |
Recombinant Mouse Aminopeptidase A/ENPEP, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 280-RA-010 |
Recombinant Human IL-1ra/IL-1F3 (10 UG) |
10 UG |
R&D SYSTEMS |
| 280-RA-010/CF |
Recombinant Human IL-1ra/IL-1F3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 280-RA-050 |
Recombinant Human IL-1ra/IL-1F3 (50 UG) |
50 UG |
R&D SYSTEMS |
| 280-RA-050/CF |
Recombinant Human IL-1ra/IL-1F3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2810-SE-010 |
Recombinant Human Proprotein Convertase 1/PCSK1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 281-CP-010 |
Recombinant Human CCL8/MCP-2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 281-CP-010/CF |
Recombinant Human CCL8/MCP-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 281-CP-050 |
Recombinant Human CCL8/MCP-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 281-CP-050/CF |
Recombinant Human CCL8/MCP-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2824-IL-010 |
Recombinant Human IL-31 (10 UG) |
10 UG |
R&D SYSTEMS |
| 2824-IL-010/CF |
Recombinant Human IL-31, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2826-TI-050 |
Recombinant Mouse TIM-4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 282-P3-010 |
Recombinant Human CCL7/MCP-3 (10 UG) |
10 UG |
R&D SYSTEMS |
| 282-P3-010/CF |
Recombinant Human CCL7/MCP-3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 282-P3-050 |
Recombinant Human CCL7/MCP-3 (50 UG) |
50 UG |
R&D SYSTEMS |
| 282-P3-050/CF |
Recombinant Human CCL7/MCP-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2834-CL-050 |
Recombinant Mouse CD5L, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2835-MG-050 |
Recombinant Mouse MGL2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2840-A3-050 |
Recombinant Human Integrin alpha 3 beta 1/VLA-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2845-GP-050 |
Recombinant Human Glypican 6, CF |
50 µg |
R&D SYSTEMS |
| 2856-ZN-010 |
Recombinant Human Carboxypeptidase A1/CPA1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2857-SE-010 |
Recombinant Mouse Mast Cell Protease-11/Prss34, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2858-SU-020 |
Recombinant Mouse Arylsulfatase A/ARSA, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2859-SL-050 |
Recombinant Human Siglec-6/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 285-IF-100 |
Recombinant Human IFN-gamma (100 UG) |
100 UG |
R&D SYSTEMS |
| 285-IF-100/CF |
Recombinant Human IFN-gamma, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 286-EP-250 |
Recombinant Human Erythropoietin (Ultrapure), CF (250 UN) |
250 UN |
R&D SYSTEMS |
| 2878-KR-050 |
Recombinant Human KIR3DL2/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 287-TC-500 |
Recombinant Human Erythropoietin (Tissue Culture Grade) (500 UN) |
500 UN |
R&D SYSTEMS |
| 2884-AD-050 |
Recombinant Human Osteoadherin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 288-TP-005 |
Recombinant Human Thrombopoietin (5 UG) |
5 UG |
R&D SYSTEMS |
| 288-TP-005/CF |
Recombinant Human Thrombopoietin, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 288-TP-025 |
Recombinant Human Thrombopoietin (25 UG) |
25 UG |
R&D SYSTEMS |
| 288-TP-025/CF |
Recombinant Human Thrombopoietin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 288-TPN-025 |
Recombinant Human Thrombopoietin (NS0) (25 UG) |
25 UG |
R&D SYSTEMS |
| 288-TPN-025/CF |
Recombinant Human Thrombopoietin (NS0), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2895-ZN-010 |
Recombinant Human Meprin beta Subunit/MEP1B, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2896-ZN-010 |
Recombinant Human Carboxypeptidase A2/CPA2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2897-ZN-010 |
Recombinant Human Carboxypeptidase B1/CPB1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2898-ZN-010 |
Recombinant Mouse Carboxypeptidase B1/CPB1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2899-ZN-010 |
Recombinant Mouse Carboxypeptidase A4/CPA4, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 289-MF-002 |
Recombinant Human MIF (2 UG) |
2 UG |
R&D SYSTEMS |
| 2900-ZN-020 |
Recombinant Human Aminoacylase/ACY1, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2904-MP-010 |
Recombinant Mouse MMP-8, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2905-SE-010 |
Recombinant Human Granzyme A, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2906-SE-010 |
Recombinant Human Granzyme B, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2907-SE-020 |
Recombinant West Nile Virus NS3 Protease, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2908-CY-010 |
Insect Cathepsin L, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| R&D SYSTEMS 产品目录列表 page 3 >> 1 2 3 4 5 6 7 8 9 10 >>..More |
